Tandem Diabetes Care Announces Third Quarter 2019 Financial Results and Updated 2019 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Tandem Diabetes (TNDM) Hits Low, Down 7.5%
November 5, 2019 2:22 PM ESTTandem Diabetes (NASDAQ: TNDM) Hits Low, Down 7.5%
... MoreTandem Diabetes (TNDM) Tops Q3 EPS by 11c, Revenues Beat; Raises FY19 Revenue Mid-Point Guidance
November 4, 2019 4:11 PM ESTTandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.09), $0.11 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $94.7 million versus the consensus estimate of $88.14 million.
Third Quarter 2019 Highlights
In comparing the third quarter of 2019 to the same period of 2018:
Worldwide pump shipments increased 112 percent to 17,839 pumps from 8,434 pumpsSales increased 105 percent to $94.7 million from $46.3 millionOperating margin improved to negative 6 percent from negative 34... More